What question did this study set out to answer?

To investigate how travel time and health insurance affect access to specialized cancer care for AYA patients with acute lymphoblastic leukemia.

December 8, 2025BloodOpen Access

Travel time and insurance status as determinants of specialized leukemia care access in adolescents and young adult (AYA) patients with acute lymphoblastic leukemia (ALL)

View Full Paper

Ask AI

Bookmark

Authors

Population-based study shows travel time and health insurance impact access to specialized leukemia treatment in adolescents and young adults.

To investigate how travel time and health insurance affect access to specialized cancer care for AYA patients with acute lymphoblastic leukemia.
Quantitative approach using population data on AYAs newly diagnosed with ALL (2004-2018) from CA, NY, and TX.
Treatment locations defined as NCI-DCC or COG; travel time calculated using geocoding techniques.
Logistic regression analysis evaluated associations between travel time, insurance type, and treatment at a specialized cancer center.
Of 4,211 AYA patients with ALL, 54.5% received treatment at specialized cancer centers (SCC).
Travel time impacted treatment access in NY, where longer travel reduced the odds of receiving care at an SCC.
Uninsured patients had significantly lower odds of treatment at SCCs compared to those with private insurance across all states.

Helen M. Parsons (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Population-based study shows travel time and health insurance impact access to specialized leukemia treatment in adolescents and young adults.